Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
261 James Street, 3f
Morristown, NJ 07960Phone+1 973-998-5926Fax+1 973-538-4957
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Orthopaedic Surgery, 1966 - 1969- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 1965 - 1966
Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1964 - 1965
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1964
Certifications & Licensure
NJ State Medical License 1966 - 2025- American Board of Orthopaedic Surgery Orthopaedic Surgery
Publications & Presentations
PubMed
- 223 citationsResveratrol-Associated Renal ToxicityJames A. Crowell, Peter J. Korytko, Robert L. Morrissey, Tristan D. Booth, Barry S. Levine
Toxicological Sciences. 2004-12-01 - 35 citationsThe effects of tetrathiomolybdate (TTM, NSC-714598) and copper supplementation on fertility and early embryonic development in ratsAlexander V. Lyubimov, Jeffry A. Smith, Serge D. Rousselle, Michael D. Mercieca, Joseph E. Tomaszewski
Reproductive Toxicology. 2004-12-01 - 25 citationsIndole-3-carbinol, but not its major digestive product 3,3′-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450James A. Crowell, John G. Page, Barry S. Levine, Michael J. Tomlinson, Charles D. Hébert
Toxicology and Applied Pharmacology. 2006-03-01
Grant Support
- Fourteen Day Oral Rangefinding Study In Rats And Dogs AnDivision Of Cancer Prevention And Control1999–2001
- Toxicological Evaluations Of Potential Medications ToNational Institute On Drug Abuse1999–2000
- Preclinical Toxicology &Pharmacology Of Drugs DevelopedDivision Of Cancer Treatment1998–2000
- Pharmacokinetic &Tissue Distribution Of C14-LycopeneDivision Of Cancer Prevention And Control1998–2000
- Preclinical Toxicology - Evaluation Of Hydrongen Ion CONDivision Of Cancer Prevention And Control1999
- Segment II Teratology StudiesDivision Of Cancer Prevention And Control1997–1999
- Four Week Oral Comparative Endocrinology StudiesDivision Of Cancer Prevention And Control1997–1999
- Oral Range And Toxicity Of 2,3-Dithiol-3-ThioneDivision Of Cancer Prevention And Control1998
- 13 Week Oral Toxicity Studies Of Two ChemopreventivesDivision Of Cancer Prevention And Control1997
- Preclinical Pharmacology Of Cancer And AIDS DrugsDivision Of Cancer Treatment1993
- Preclinical Toxicology Studies Ws#24 And #25Division Of Cancer Prevention And Control1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
